カテゴリー： QYResearch, 世界

多嚢胞性卵巣症候群（PCOS）治療法の世界市場：規模・現状・予測2019-2025

【英語タイトル】Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料（DATA909X18843）・商品コード：DATA909X18843
・発行会社（調査会社）：QYResearch
・発行日：2019年11月25日（※2024年版があります。お問い合わせください）
・ページ数：92
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,900 ⇒換算￥577,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,850 ⇒換算￥865,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,800 ⇒換算￥1,154,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※当調査レポートでは、多嚢胞性卵巣症候群（PCOS）治療法の世界市場について調査・分析し、多嚢胞性卵巣症候群（PCOS）治療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（経口避妊薬、排卵誘発剤、顔面発毛抑制剤、インスリン感作剤）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。


・レポートの概要
・世界の多嚢胞性卵巣症候群（PCOS）治療法市場動向
・主要企業別マーケットシェア
・多嚢胞性卵巣症候群（PCOS）治療法の種類別市場規模2014-2019
（経口避妊薬、排卵誘発剤、顔面発毛抑制剤、インスリン感作剤）
・多嚢胞性卵巣症候群（PCOS）治療法の用途別市場規模2014-2019
（病院、診療所、その他）
・多嚢胞性卵巣症候群（PCOS）治療法の北米市場：主要企業・種類別/用途別市場規模
・多嚢胞性卵巣症候群（PCOS）治療法のヨーロッパ市場：主要企業・種類別/用途別市場規模
・多嚢胞性卵巣症候群（PCOS）治療法の中国市場：主要企業・種類別/用途別市場規模
・多嚢胞性卵巣症候群（PCOS）治療法の日本国内市場：主要企業・種類別/用途別市場規模
・多嚢胞性卵巣症候群（PCOS）治療法の東南アジア市場：主要企業・種類別/用途別市場規模
・多嚢胞性卵巣症候群（PCOS）治療法のインド市場：主要企業・種類別/用途別市場規模
・多嚢胞性卵巣症候群（PCOS）治療法の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Bristol Myers Squibb、Crinetics Pharmaceuticals, Inc.、EffRx, Inc.、Ferring Pharmaceuticals、Merck KGaA、Neurocrine Biosciences, Inc.、Novartis Pharmaceuticals、Pfizer Inc.、Sanofi Aventis、Teva Pharmaceutical Industries Limited）
・多嚢胞性卵巣症候群（PCOS）治療法の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...
【レポートの概要】

Polycystic ovarian syndrome (PCOS) is one of the most common endocrine disorders among women of reproductive age. In 2018, the global Polycystic Ovarian Syndrome (PCOS) Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Polycystic Ovarian Syndrome (PCOS) Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Polycystic Ovarian Syndrome (PCOS) Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Bristol Myers Squibb
Crinetics Pharmaceuticals, Inc.
EffRx, Inc.
Ferring Pharmaceuticals
Merck KGaA
Neurocrine Biosciences, Inc.
Novartis Pharmaceuticals
Pfizer Inc.
Sanofi Aventis
Teva Pharmaceutical Industries Limited

Market segment by Type, the product can be split into
Oral Contraceptive
Ovulation Inducing Agents
Facial Hair Growth Inhibitor
Insulin Sensitizing Agent

Market segment by Application, split into
Hospitals
Clinic
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Polycystic Ovarian Syndrome (PCOS) Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Polycystic Ovarian Syndrome (PCOS) Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Polycystic Ovarian Syndrome (PCOS) Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Oral Contraceptive
1.4.3 Ovulation Inducing Agents
1.4.4 Facial Hair Growth Inhibitor
1.4.5 Insulin Sensitizing Agent
1.5 Market by Application
1.5.1 Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Share by Application (2019-2025)
1.5.2 Hospitals
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size
2.2 Polycystic Ovarian Syndrome (PCOS) Therapeutics Growth Trends by Regions
2.2.1 Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Regions (2019-2025)
2.2.2 Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by by Players
3.1.1 Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Revenue by by Players (2014-2019)
3.1.2 Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Revenue Market Share by by Players (2014-2019)
3.1.3 Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Polycystic Ovarian Syndrome (PCOS) Therapeutics Key Players Head office and Area Served
3.3 Key Players Polycystic Ovarian Syndrome (PCOS) Therapeutics Product/Solution/Service
3.4 Date of Enter into Polycystic Ovarian Syndrome (PCOS) Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Type (2014-2019)
4.2 Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Application (2014-2019)

5 North America
5.1 North America Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size (2014-2019)
5.2 Polycystic Ovarian Syndrome (PCOS) Therapeutics Key Players in North America
5.3 North America Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Type
5.4 North America Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Application

6 Europe
6.1 Europe Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size (2014-2019)
6.2 Polycystic Ovarian Syndrome (PCOS) Therapeutics Key Players in Europe
6.3 Europe Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Type
6.4 Europe Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Application

7 China
7.1 China Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size (2014-2019)
7.2 Polycystic Ovarian Syndrome (PCOS) Therapeutics Key Players in China
7.3 China Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Type
7.4 China Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Application

8 Japan
8.1 Japan Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size (2014-2019)
8.2 Polycystic Ovarian Syndrome (PCOS) Therapeutics Key Players in Japan
8.3 Japan Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Type
8.4 Japan Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size (2014-2019)
9.2 Polycystic Ovarian Syndrome (PCOS) Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Type
9.4 Southeast Asia Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Application

10 India
10.1 India Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size (2014-2019)
10.2 Polycystic Ovarian Syndrome (PCOS) Therapeutics Key Players in India
10.3 India Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Type
10.4 India Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size (2014-2019)
11.2 Polycystic Ovarian Syndrome (PCOS) Therapeutics Key Players in Central & South America
11.3 Central & South America Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Type
11.4 Central & South America Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Application

12 International Players Profiles
12.1 Bristol Myers Squibb
12.1.1 Bristol Myers Squibb Company Details
12.1.2 Company Description and Business Overview
12.1.3 Polycystic Ovarian Syndrome (PCOS) Therapeutics Introduction
12.1.4 Bristol Myers Squibb Revenue in Polycystic Ovarian Syndrome (PCOS) Therapeutics Business (2014-2019))
12.1.5 Bristol Myers Squibb Recent Development
12.2 Crinetics Pharmaceuticals, Inc.
12.2.1 Crinetics Pharmaceuticals, Inc. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Polycystic Ovarian Syndrome (PCOS) Therapeutics Introduction
12.2.4 Crinetics Pharmaceuticals, Inc. Revenue in Polycystic Ovarian Syndrome (PCOS) Therapeutics Business (2014-2019)
12.2.5 Crinetics Pharmaceuticals, Inc. Recent Development
12.3 EffRx, Inc.
12.3.1 EffRx, Inc. Company Details
12.3.2 Company Description and Business Overview
12.3.3 Polycystic Ovarian Syndrome (PCOS) Therapeutics Introduction
12.3.4 EffRx, Inc. Revenue in Polycystic Ovarian Syndrome (PCOS) Therapeutics Business (2014-2019)
12.3.5 EffRx, Inc. Recent Development
12.4 Ferring Pharmaceuticals
12.4.1 Ferring Pharmaceuticals Company Details
12.4.2 Company Description and Business Overview
12.4.3 Polycystic Ovarian Syndrome (PCOS) Therapeutics Introduction
12.4.4 Ferring Pharmaceuticals Revenue in Polycystic Ovarian Syndrome (PCOS) Therapeutics Business (2014-2019)
12.4.5 Ferring Pharmaceuticals Recent Development
12.5 Merck KGaA
12.5.1 Merck KGaA Company Details
12.5.2 Company Description and Business Overview
12.5.3 Polycystic Ovarian Syndrome (PCOS) Therapeutics Introduction
12.5.4 Merck KGaA Revenue in Polycystic Ovarian Syndrome (PCOS) Therapeutics Business (2014-2019)
12.5.5 Merck KGaA Recent Development
12.6 Neurocrine Biosciences, Inc.
12.6.1 Neurocrine Biosciences, Inc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Polycystic Ovarian Syndrome (PCOS) Therapeutics Introduction
12.6.4 Neurocrine Biosciences, Inc. Revenue in Polycystic Ovarian Syndrome (PCOS) Therapeutics Business (2014-2019)
12.6.5 Neurocrine Biosciences, Inc. Recent Development
12.7 Novartis Pharmaceuticals
12.7.1 Novartis Pharmaceuticals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Polycystic Ovarian Syndrome (PCOS) Therapeutics Introduction
12.7.4 Novartis Pharmaceuticals Revenue in Polycystic Ovarian Syndrome (PCOS) Therapeutics Business (2014-2019)
12.7.5 Novartis Pharmaceuticals Recent Development
12.8 Pfizer Inc.
12.8.1 Pfizer Inc. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Polycystic Ovarian Syndrome (PCOS) Therapeutics Introduction
12.8.4 Pfizer Inc. Revenue in Polycystic Ovarian Syndrome (PCOS) Therapeutics Business (2014-2019)
12.8.5 Pfizer Inc. Recent Development
12.9 Sanofi Aventis
12.9.1 Sanofi Aventis Company Details
12.9.2 Company Description and Business Overview
12.9.3 Polycystic Ovarian Syndrome (PCOS) Therapeutics Introduction
12.9.4 Sanofi Aventis Revenue in Polycystic Ovarian Syndrome (PCOS) Therapeutics Business (2014-2019)
12.9.5 Sanofi Aventis Recent Development
12.10 Teva Pharmaceutical Industries Limited
12.10.1 Teva Pharmaceutical Industries Limited Company Details
12.10.2 Company Description and Business Overview
12.10.3 Polycystic Ovarian Syndrome (PCOS) Therapeutics Introduction
12.10.4 Teva Pharmaceutical Industries Limited Revenue in Polycystic Ovarian Syndrome (PCOS) Therapeutics Business (2014-2019)
12.10.5 Teva Pharmaceutical Industries Limited Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Polycystic Ovarian Syndrome (PCOS) Therapeutics Key Market Segments
Table Key Players Polycystic Ovarian Syndrome (PCOS) Therapeutics Covered
Table Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Oral Contraceptive Figures
Table Key Players of Oral Contraceptive
Figuer Ovulation Inducing Agents Figures
Table Key Players of Ovulation Inducing Agents
Figuer Facial Hair Growth Inhibitor Figures
Table Key Players of Facial Hair Growth Inhibitor
Figuer Insulin Sensitizing Agent Figures
Table Key Players of Insulin Sensitizing Agent
Table Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Share by Application in 2018 & 2025
Figure Hospitals Case Studies
Figure Clinic Case Studies
Figure Others Case Studies
Figure Polycystic Ovarian Syndrome (PCOS) Therapeutics Report Years Considered
Figure Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Regions 2019-2025 (Million US$)
Table Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Regions 2019-2025 (Million US$)
Table Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Share by Regions 2014-2019
Figure Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Share by Regions 2014-2019
Figure Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Revenue by by Players (2014-2019) (Million US$)
Table Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Share by by Players (2014-2019)
Figure Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Share by by Players in 2018
Table Global Polycystic Ovarian Syndrome (PCOS) Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Polycystic Ovarian Syndrome (PCOS) Therapeutics Product/Solution/Service
Table Date of Enter into Polycystic Ovarian Syndrome (PCOS) Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size Share by Type (2014-2019)
Figure Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size Share by Application (2014-2019)
Figure Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Revenue Market Share by Application in 2018
Figure North America Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size 2014-2019 (Million US$)
Table North America Key Players Polycystic Ovarian Syndrome (PCOS) Therapeutics Revenue (2018-2019) (Million US$)
Table North America Key Players Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Share (2018-2019)
Table North America Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Type 2014-2019 (Million US$)
Table North America Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Share by Type 2014-2019
Table North America Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Application 2014-2019 (Million US$)
Table North America Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Share by Application 2014-2019
Figure Europe Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Polycystic Ovarian Syndrome (PCOS) Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Share (2018-2019)
Table Europe Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Europe Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Share by Type 2014-2019
Table Europe Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Europe Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Share by Application 2014-2019
Figure China Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Polycystic Ovarian Syndrome (PCOS) Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Share (2018-2019)
Table China Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Type 2014-2019 (Million US$)
Table China Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Share by Type 2014-2019
Table China Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Application 2014-2019 (Million US$)
Table China Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Share by Application 2014-2019
Figure Japan Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Polycystic Ovarian Syndrome (PCOS) Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Share (2018-2019)
Table Japan Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Japan Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Share by Type 2014-2019
Table Japan Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Japan Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Share by Application 2014-2019
Figure Southeast Asia Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Polycystic Ovarian Syndrome (PCOS) Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Share (2018-2019)
Table Southeast Asia Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Share by Type 2014-2019
Table Southeast Asia Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Share by Application 2014-2019
Figure India Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Polycystic Ovarian Syndrome (PCOS) Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Share (2018-2019)
Table India Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Type 2014-2019 (Million US$)
Table India Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Share by Type 2014-2019
Table India Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Application 2014-2019 (Million US$)
Table India Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Share by Application 2014-2019
Figure Central & South America Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Polycystic Ovarian Syndrome (PCOS) Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Share (2018-2019)
Table Central & South America Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Central & South America Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Share by Type 2014-2019
Table Central & South America Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Central & South America Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Share by Application 2014-2019
Table Bristol Myers Squibb Company Details
Table Bristol Myers Squibb Revenue in Polycystic Ovarian Syndrome (PCOS) Therapeutics Business 2014-2019 (Million US$)
Figure Bristol Myers Squibb Revenue Growth Rate in Polycystic Ovarian Syndrome (PCOS) Therapeutics Business (2014-2019)
Table Bristol Myers Squibb Recent Development
Table Crinetics Pharmaceuticals, Inc. Company Details
Table Crinetics Pharmaceuticals, Inc. Revenue in Polycystic Ovarian Syndrome (PCOS) Therapeutics Business 2014-2019 (Million US$)
Figure Crinetics Pharmaceuticals, Inc. Revenue Growth Rate in Polycystic Ovarian Syndrome (PCOS) Therapeutics Business (2014-2019)
Table Crinetics Pharmaceuticals, Inc. Recent Development
Table EffRx, Inc. Company Details
Table EffRx, Inc. Revenue in Polycystic Ovarian Syndrome (PCOS) Therapeutics Business 2014-2019 (Million US$)
Figure EffRx, Inc. Revenue Growth Rate in Polycystic Ovarian Syndrome (PCOS) Therapeutics Business (2014-2019)
Table EffRx, Inc. Recent Development
Table Ferring Pharmaceuticals Company Details
Table Ferring Pharmaceuticals Revenue in Polycystic Ovarian Syndrome (PCOS) Therapeutics Business 2014-2019 (Million US$)
Figure Ferring Pharmaceuticals Revenue Growth Rate in Polycystic Ovarian Syndrome (PCOS) Therapeutics Business (2014-2019)
Table Ferring Pharmaceuticals Recent Development
Table Merck KGaA Company Details
Table Merck KGaA Revenue in Polycystic Ovarian Syndrome (PCOS) Therapeutics Business 2014-2019 (Million US$)
Figure Merck KGaA Revenue Growth Rate in Polycystic Ovarian Syndrome (PCOS) Therapeutics Business (2014-2019)
Table Merck KGaA Recent Development
Table Neurocrine Biosciences, Inc. Company Details
Table Neurocrine Biosciences, Inc. Revenue in Polycystic Ovarian Syndrome (PCOS) Therapeutics Business 2014-2019 (Million US$)
Figure Neurocrine Biosciences, Inc. Revenue Growth Rate in Polycystic Ovarian Syndrome (PCOS) Therapeutics Business (2014-2019)
Table Neurocrine Biosciences, Inc. Recent Development
Table Novartis Pharmaceuticals Company Details
Table Novartis Pharmaceuticals Revenue in Polycystic Ovarian Syndrome (PCOS) Therapeutics Business 2014-2019 (Million US$)
Figure Novartis Pharmaceuticals Revenue Growth Rate in Polycystic Ovarian Syndrome (PCOS) Therapeutics Business (2014-2019)
Table Novartis Pharmaceuticals Recent Development
Table Pfizer Inc. Company Details
Table Pfizer Inc. Revenue in Polycystic Ovarian Syndrome (PCOS) Therapeutics Business 2014-2019 (Million US$)
Figure Pfizer Inc. Revenue Growth Rate in Polycystic Ovarian Syndrome (PCOS) Therapeutics Business (2014-2019)
Table Pfizer Inc. Recent Development
Table Sanofi Aventis Company Details
Table Sanofi Aventis Revenue in Polycystic Ovarian Syndrome (PCOS) Therapeutics Business 2014-2019 (Million US$)
Figure Sanofi Aventis Revenue Growth Rate in Polycystic Ovarian Syndrome (PCOS) Therapeutics Business (2014-2019)
Table Sanofi Aventis Recent Development
Table Teva Pharmaceutical Industries Limited Company Details
Table Teva Pharmaceutical Industries Limited Revenue in Polycystic Ovarian Syndrome (PCOS) Therapeutics Business 2014-2019 (Million US$)
Figure Teva Pharmaceutical Industries Limited Revenue Growth Rate in Polycystic Ovarian Syndrome (PCOS) Therapeutics Business (2014-2019)
Table Teva Pharmaceutical Industries Limited Recent Development
Table Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size Share by Regions in 2025
Figure North America Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Product (2019-2025)
Figure Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Product in 2025
Table Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Application (2019-2025)
Figure Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Bristol Myers Squibb、Crinetics Pharmaceuticals, Inc.、EffRx, Inc.、Ferring Pharmaceuticals、Merck KGaA、Neurocrine Biosciences, Inc.、Novartis Pharmaceuticals、Pfizer Inc.、Sanofi Aventis、Teva Pharmaceutical Industries Limited

★調査レポート[多嚢胞性卵巣症候群（PCOS）治療法の世界市場：規模・現状・予測2019-2025] (コード：DATA909X18843)販売に関する免責事項を必ずご確認ください。
★調査レポート[多嚢胞性卵巣症候群（PCOS）治療法の世界市場：規模・現状・予測2019-2025]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の多嚢胞性卵巣症候群（PCOS）治療薬市場 2019年
    DATA909X13285 / QYResearch / 2019年11月20日 / ※本調査レポートは、多嚢胞性卵巣症候群（PCOS）治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、経口避妊薬、抗炎症薬、インスリン抵抗性改善薬、抗高血圧薬、抗肥満薬に、用途別には、病院、クリニックにセグメント区分し、多嚢胞性卵巣症候群（PCOS）治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・多嚢胞性卵巣症候群（PCOS）治療薬の世界市場概要 ・多嚢胞性卵巣症候群（PCOS）治療薬の製造コスト構成分析 ・多嚢胞性卵巣症候群（PCOS）治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・多嚢胞性卵巣症候群（PCOS）治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・多嚢胞性卵巣症候群（PCOS）治療薬のセグメント分析（種類別） （経口避妊薬、抗炎症薬、インスリン抵抗性改善薬、抗高血圧薬、抗肥満薬）...The global Polycystic Ovary Syndrome (PCOS) Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Polycystic Ovary Syndrome (PCOS) Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Polycystic Ovary Syndrome (PCOS) Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Polycystic Ovary Syndrome (PCOS) Drugs in North America, Europe, China, Japan, Southeast Asia and...
  • 多嚢胞性卵巣症候群治療の世界市場：規模・現状・予測2019-2025
    DATA909X18844 / QYResearch / 2019年11月25日 / ※当調査レポートでは、多嚢胞性卵巣症候群治療の世界市場について調査・分析し、多嚢胞性卵巣症候群治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（経口避妊薬、インスリン抵抗性改善薬、抗うつ薬、オルニチンデカルボキシラーゼ阻害薬、アロマターゼ阻害薬、利尿薬）、用途別（病院薬局、ドラッグストア）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の多嚢胞性卵巣症候群治療市場動向 ・主要企業別マーケットシェア ・多嚢胞性卵巣症候群治療の種類別市場規模2014-2019 （経口避妊薬、インスリン抵抗性改善薬、抗うつ薬、オルニチンデカルボキシラーゼ阻害薬、アロマターゼ阻害薬、利尿薬） ・多嚢胞性卵巣症候群治療の用途別市場規模2014-2019 （病院薬局、ドラッグストア） ・多嚢胞性卵巣症候群治療の北米市場：主要企業・種類別/用途別市場規模 ・多嚢胞性卵巣症候群治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...Polycystic Ovary Syndrome Treatment means treatment of  a common hormonal endocrine disorder that affects women of child bearing age (15 to 49 years). This disease is characterized by the formation of cysts on the ovaries leading to an insufficiency of the ovulation initiating hormone in the female body.In 2018, the global Polycystic Ovary Syndrome Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Polycystic Ovary Syndrome Treatment status, future forecast, growth opportunity, key market and...
  • 卵巣がんの治療および診断の世界市場：規模・現状・予測2019-2025
    DATA909X19026 / QYResearch / 2019年11月25日 / ※当調査レポートでは、卵巣がんの治療および診断の世界市場について調査・分析し、卵巣がんの治療および診断の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（手術、放射線療法、薬物治療）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の卵巣がんの治療および診断市場動向 ・主要企業別マーケットシェア ・卵巣がんの治療および診断の種類別市場規模2014-2019 （手術、放射線療法、薬物治療） ・卵巣がんの治療および診断の用途別市場規模2014-2019 （病院、診療所、その他） ・卵巣がんの治療および診断の北米市場：主要企業・種類別/用途別市場規模 ・卵巣がんの治療および診断のヨーロッパ市場：主要企業・種類別/用途別市場規模...Ovarian cancer (ovarian cancer) accounts for 2.4% ~ 6.5% of the common malignant tumors in women, and ranks the third among the cancers of the female reproductive system, secondary to cervical cancer and uterine body cancer.In recent years, due to the prevention and treatment of cervical cancer and uterine body cancer, some achievements have been made, while the prevention and treatment of ovarian cancer is relatively small.So ovarian cancer is the leading cause of death among cancers of the reproductive system in women.In 2018, the global Therapies and Diagnostics for Ovarian Cancer market size was xx million US$ and it...

    • ◆H&Iグローバルリサーチのお客様（例）◆